These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8665076)

  • 1. Induction of immunological tolerance to islet allografts.
    Rossini AA; Parker DC; Phillips NE; Durie FH; Noelle RJ; Mordes JP; Greiner DL
    Cell Transplant; 1996; 5(1):49-52. PubMed ID: 8665076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts.
    Zheng XX; Li Y; Li XC; Roy-Chaudhury P; Nickerson P; Tian Y; Sayegh MH; Strom TB
    Transplant Proc; 1999; 31(1-2):627-8. PubMed ID: 10083268
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody.
    Rossini AA; Mordes JP; Markees TG; Phillips NE; Gordon EJ; Greiner DL
    Transplant Proc; 1999; 31(1-2):629-32. PubMed ID: 10083269
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.
    Larsen CP; Alexander DZ; Hollenbaugh D; Elwood ET; Ritchie SC; Aruffo A; Hendrix R; Pearson TC
    Transplantation; 1996 Jan; 61(1):4-9. PubMed ID: 8560571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface.
    Rastellini C; Salam A; Kuddus R; Aitouche A; Braun M; Leach R; Peach R; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):845. PubMed ID: 10083368
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.
    Parker DC; Greiner DL; Phillips NE; Appel MC; Steele AW; Durie FH; Noelle RJ; Mordes JP; Rossini AA
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9560-4. PubMed ID: 7568172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged skin allograft survival in mice treated with Flt3-ligand-induced dendritic cells and anti-CD154 monoclonal antibody.
    Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Maliszewski C; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1999; 31(1-2):884-5. PubMed ID: 10083387
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
    Rastellini C; Salam A; Kuddus R; Aitouche A; Subbotin V; Braun M; Leach R; Peach R; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):1242-3. PubMed ID: 10083554
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.